Layer-specific differences in reactive oxygen species levels after oxygen-glucose deprivation in acute hippocampal slices.

Free Radic Biol Med

Laboratory of Cellular Pharmacology, Institute of Experimental Medicine, Hungarian Academy of Sciences, 1083 Budapest, Szigony u. 43., Hungary.

Published: March 2008

The major role of reactive oxygen species (ROS) in the pathomechanism of ischemia have been widely recognized. Still, measurements of the precise time course and regional distribution of ischemia-induced ROS level changes in acute brain slices have been missing. By using acute hippocampal slices and the fluorescent dye CM-H2DCFDA, we showed that reoxygenation after in vitro ischemia (oxygen-glucose deprivation; OGD) increased ROS levels in the hippocampal CA1 layers vulnerable to ischemia but did not have significant effects in the resistant stratum granulosum in the dentate gyrus (DG). Production of ROS started during OGD, but, contrary to reoxygenation, it manifested as a ROS level increase exclusively in the presence of catalase and glutathione peroxidase inhibition. The mechanism of ROS production involves the activation of NMDA receptors and nitric oxide synthases. The inhibition of ROS response by either AP-5 or L-NAME together with the ROS sensitivity profile of the dye suggest that peroxynitrite, the reaction product of superoxide and nitric oxide, plays a role in the response. Direct visualization of layer-specific effects of ROS production and its scavenging, shown for the first time in acute hippocampal slices, suggests that distinct ROS homeostasis may underlie the different ischemic vulnerability of CA1 and DG.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.freeradbiomed.2007.11.022DOI Listing

Publication Analysis

Top Keywords

acute hippocampal
12
hippocampal slices
12
ros
10
reactive oxygen
8
oxygen species
8
oxygen-glucose deprivation
8
ros level
8
ros production
8
nitric oxide
8
layer-specific differences
4

Similar Publications

Background: Fabry disease (FD) patients are known to be at high risk of developing neuropsychiatric symptoms such as anxiety, depression and cognitive deficits. Despite this, they are underdiagnosed and inadequately treated. It is unknown whether these symptoms arise from pathological glycosphingolipid deposits or from cerebrovascular abnormalities affecting neuronal functions in the central nervous system.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

Alzheimer's Disease Research Center, New York University Langone Health, New York, NY, USA.

Background: Cognitive impairment is one of the most frequently reported post-acute sequelae of COVID-19, yet the pathophysiology underpinning this symptom remains unknown. We aimed to explore the correlation of blood markers of inflammation, BBB disruption and neurodegeneration with MRI volume measurements in COVID-19 patients with and without cognitive impairment, and among patients with no prior history of COVID-19.

Method: We conducted a prospective study of COVID-19 patients (COV+; laboratory verified SARS-CoV-2 infection) and non-COVID-19 controls (COV-; no history of SARS-CoV-2 infection and negative SARS-CoV-2 nucleocapsid antibody).

View Article and Find Full Text PDF

Public Health.

Alzheimers Dement

December 2024

University of Illinois Urbana-Champaign, Champaign, IL, USA.

Background: No study has synthesized evidence from randomized controlled trials (RCTs) testing the acute and chronic effects of reallocating sedentary time (ST) to physical activity (PA) on cognitive and brain health across the lifespan.

Method: Seven academic databases were systematically searched on October 26, 2022, with an updated search on June 23, 2023. Inclusion criteria encompassed RCTs published in English involving healthy participants aged ≥ 4 years.

View Article and Find Full Text PDF

Background: Persistent neurological symptoms including cognitive impairment can follow SARS-CoV-2 infection, a condition termed neurological post-acute sequelae of COVID-19 (Neuro-PASC). Structural brain differences have been observed in individuals with Neuro-PASC, raising concern that COVID-19 may promote age-related neurodegeneration. However, the mechanisms by which COVID-19 impairs cognition and its impact on brain aging, remain poorly characterized.

View Article and Find Full Text PDF

Background: Epidemiological studies indicate that chronic short sleep and/or disrupted sleep are all associated with metabolic dysfunction, cardiovascular risk, cognitive impairments, and increased risk for Alzheimer's disease. We have shown that acute sleep deprivation disrupts proteostasis, leading to the activation of an adaptive endoplasmic reticulum (ER) stress response known as the unfolded protein response (UPR). However, prolonged ER stress triggers the integrated stress response, which has been implicated in memory impairments.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!